Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jing Jiang, Yimeng Xia, Yi Liang, Meiling Yang, Wen Zeng & Xiaocong Zeng. (2018) miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3777-3790.
Read now
Read now
Articles from other publishers (17)
Yong Suk Jo. (2022) Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review. Tuberculosis and Respiratory Diseases 85:4, pages 289-301.
Crossref
Crossref
Kyuho Lee, Mina Kim, Namo Kim, Su Jeong Kang & Young Jun Oh. (2022) Effects of Iloprost on Arterial Oxygenation and Lung Mechanics during One-Lung Ventilation in Supine-Positioned Patients: A Randomized Controlled Study. Journal of Personalized Medicine 12:7, pages 1054.
Crossref
Crossref
Xinhui Wu, I. Sophie T. BosThomas M. Conlon, Meshal Ansari, Vicky VerschutLuke van der Koog, Lars A. VerkleijAngela D’AmbrosiAleksey Matveyenko, Herbert B. SchillerMelanie Königshoff, Martina SchmidtLoes E. M. KistemakerAli Önder Yildirim & Reinoud Gosens. (2022) A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration. Science Advances 8:12.
Crossref
Crossref
Kyuho Lee, Young Jun Oh, Mina Kim, Sei Han Song & Namo Kim. (2022) Effects of Iloprost on Oxygenation during One-Lung Ventilation in Patients with Low Diffusing Capacity for Carbon Monoxide: A Randomized Controlled Study. Journal of Clinical Medicine 11:6, pages 1542.
Crossref
Crossref
Danfen Yang, Li Wang, Pengfei Jiang, Rui Kang & Yuanyuan Xie. (2022) Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension. Journal of Healthcare Engineering 2022, pages 1-9.
Crossref
Crossref
Kareem Ahmad, Vikramjit Khangoora & Steven D. Nathan. (2022) Lung Disease–Related Pulmonary Hypertension. Cardiology Clinics 40:1, pages 77-88.
Crossref
Crossref
Jennifer L. Keen & Thenappan Thenappan. (2021) Shifting gears: the search for group 3 pulmonary hypertension treatment. Current Opinion in Pulmonary Medicine 27:5, pages 296-302.
Crossref
Crossref
Aaron WaxmanRicardo Restrepo-JaramilloThenappan ThenappanAshwin RavichandranPeter EngelAbubakr BajwaRoblee AllenJeremy FeldmanRahul ArgulaPeter SmithKristan RollinsChunqin DengLeigh PetersonHeidi BellVictor TapsonSteven D. Nathan. (2021) Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease. New England Journal of Medicine 384:4, pages 325-334.
Crossref
Crossref
Eileen M. Harder & Aaron B. Waxman. (2020) Clinical trials in group 3 pulmonary hypertension. Current Opinion in Pulmonary Medicine 26:5, pages 391-396.
Crossref
Crossref
Gulsev Ozen, Yasmine Amgoud, Heba Abdelazeem, Salma Mani, Chabha Benyahia, Amel Bouhadoun, Alexy Tran-Dinh, Yves Castier, Alice Guyard, Dan Longrois, Adam M. Silverstein & Xavier Norel. (2020) Downregulation of PGI2 pathway in Pulmonary Hypertension Group-III patients. Prostaglandins, Leukotrienes and Essential Fatty Acids 160, pages 102158.
Crossref
Crossref
Gulsev Ozen, Chabha Benyahia, Yasmine Amgoud, Jigisha Patel, Heba Abdelazeem, Amel Bouhadoun, Sonia Yung, Fangfang Li, Youcef Mahieddine, Adam M. Silverstein, Yves Castier, Aurélie Cazes, Dan Longrois, Lucie H. Clapp & Xavier Norel. (2020) Interaction between PGI2 and ET-1 pathways in vascular smooth muscle from Group-III pulmonary hypertension patients. Prostaglandins & Other Lipid Mediators 146, pages 106388.
Crossref
Crossref
Steven J. Cassady & Robert M. Reed. (2019) Pulmonary Hypertension in COPD: A Case Study and Review of the Literature. Medicina 55:8, pages 432.
Crossref
Crossref
Hoon Choi, Joonpyo Jeon, Jaewon Huh, Jungmin Koo, Sungwon Yang & Wonjung Hwang. (2019) The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial. Journal of Clinical Medicine 8:7, pages 982.
Crossref
Crossref
Isaac Almendros, Sébastien Baillieul, Candela Caballero, Luiza Helena Degani-Costa, Michael Furian, Camila Hirotsu, Zafeiris Louvaris, Sira Thiel & Christopher D. Turnbull. (2019) Highlights from the 2018 European Respiratory Society International Congress: sleep and clinical physiology. ERJ Open Research 5:3, pages 00201-2018.
Crossref
Crossref
Atike TEKELİ KUNT, Selim İSBİR, Ali CİVELEK, Serdar AKGUN, Arzu ERGEN, Ozlem YAPİCİER, Aydin SAV & Sinan ARSAN. (2018) Prevention of lung injury by iloprost following hind limb ischemia and reperfuison model in ratsSıçanlarda alt ekstremite iskemi reperfüzyon hasarını takiben gelişen akciğer hasarının iloprost ile önlenmesi. Turkish Journal of Clinics and Laboratory 9:2, pages 76-80.
Crossref
Crossref
Rade Tomic & Marshall I. Hertz. (2018) Secondary pulmonary arterial hypertension. Current Opinion in Organ Transplantation 23:3, pages 324-329.
Crossref
Crossref
Melissa L. Thompson Bastin & Brittany D. Bissell. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
507
514
.